Gross Margin
5.32%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives 13.46%.Updated Oct 25, 2026Profit Margin
-39.90%vs Specialty Chemicals peers Provider-reported. Net Income (TTM) ÷ Revenue (TTM) on this page gives -35.06%.Updated Oct 25, 2026Operating Margin
-9.24%vs Specialty Chemicals peers Updated Oct 25, 2026Return on Assets (TTM)
-0.45%vs Specialty Chemicals peers Updated Oct 25, 2026Return on Equity (TTM)
-12.78%vs Specialty Chemicals peers Updated Oct 25, 2026Revenue (TTM)
5.84BTRY117.36M · vs all stocks (USD) Updated Oct 25, 2026Revenue per Share (TTM)
1.55TRYUpdated Oct 25, 2026Quarterly Revenue Growth
-13.80%vs Specialty Chemicals peers Updated Oct 25, 2026Gross Profit (TTM)
785.68MTRY15.80M · vs all stocks (USD) Updated Oct 25, 2026EBITDA (TTM)
363.54MTRY7.31M · vs all stocks (USD) Updated Oct 25, 2026Net Income (TTM)
-2.05BTRY-41.14M · vs all stocks (USD) Updated Oct 25, 2026Quarterly Earnings Growth (YoY)
13.86%vs Specialty Chemicals peers Updated Oct 25, 2026Operating Cash Flow (TTM)
1.03BTRY20.75M · vs all stocks (USD) Updated Oct 25, 2026Levered Free Cash Flow (TTM)
1.86BTRY37.37M · vs all stocks (USD) Updated Oct 25, 20265-Year Average Dividend Yield
0.54%Updated Oct 25, 2026Payout Ratio
15.97%vs Specialty Chemicals peers Updated Oct 25, 2026Revenue
6.40BTRYFY2025 · Dec 31, 2025Cost of Goods Sold
5.03BTRYFY2025 · Dec 31, 2025Gross Profit
1.38BTRYFY2025 · Dec 31, 2025Operating Income
545.14MTRY10.96M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-678.26MTRYFY2025 · Dec 31, 2025Income Tax Expense
210.97MTRYFY2025 · Dec 31, 2025Net Income
-1.44BTRYFY2025 · Dec 31, 2025EBIT
-404.53MTRYFY2025 · Dec 31, 2025EBITDA (Income Statement)
363.54MTRYFY2025 · Dec 31, 2025Research & Development
91.57MTRYFY2025 · Dec 31, 2025Selling, General & Administrative
193.14MTRYFY2025 · Dec 31, 2025Other Operating Expenses
83.73MTRYFY2025 · Dec 31, 2025Non-operating Interest Income
59.93MTRYFY2025 · Dec 31, 2025Non-operating Interest Expense
273.73MTRYFY2025 · Dec 31, 2025EPS (Basic)
-0.9660TRYFY2025 · Dec 31, 2025EPS (Diluted)
-0.9660TRYFY2025 · Dec 31, 2025Basic Shares Outstanding
1.49BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
1.49BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-1.44BTRYFY2025 · Dec 31, 2025Minority Interests (P&L)
0.00TRYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TRYFY2025 · Dec 31, 2025Operating Cash Flow
-1.13BTRYFY2025 · Dec 31, 2025Free Cash Flow
-1.89BTRYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
282.58MTRYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-1.44BTRYFY2025 · Dec 31, 2025Other Non-cash Items
192.26MTRYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
165.91MTRYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-49.51MTRYFY2025 · Dec 31, 2025Capital Expenditures
-753.87MTRYFY2025 · Dec 31, 2025Net Investing Cash Flow
-753.87MTRYFY2025 · Dec 31, 2025Long-term Debt Issuance
2.75BTRYFY2025 · Dec 31, 2025Long-term Debt Payments
-1.31BTRYFY2025 · Dec 31, 2025Other Financing Charges
-980.81MTRYFY2025 · Dec 31, 2025Net Financing Cash Flow
463.14MTRYFY2025 · Dec 31, 2025